<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32492924</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>S100A6 and Its Brain Ligands in Neurodegenerative Disorders.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3979</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21113979</ELocationID><Abstract><AbstractText>The S100A6 protein is present in different mammalian cells and tissues including the brain. It binds Ca<sup>2+</sup> and Zn<sup>2+</sup> and interacts with many target proteins/ligands. The best characterized ligands of S100A6, expressed at high level in the brain, include CacyBP/SIP and Sgt1. Research concerning the functional role of S100A6 and these two ligands indicates that they are involved in various signaling pathways that regulate cell proliferation, differentiation, cytoskeletal organization, and others. In this review, we focused on the expression/localization of these proteins in the brain and on their possible role in neurodegenerative diseases. Published results demonstrate that S100A6, CacyBP/SIP, and Sgt1 are expressed in various brain structures and in the spinal cord and can be found in different cell types including neurons and astrocytes. When it comes to their possible involvement in nervous system pathology, it is evident that their expression/level and/or subcellular localization is changed when compared to normal conditions. Among diseases in which such changes have been observed are Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), epileptogenesis, Parkinson's disease (PD), Huntington's disease (HD), and others.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Filipek</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#x15b;niak</LastName><ForeName>Wies&#x142;awa</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018/29/B/NZ4/01384</GrantID><Agency>Narodowe Centrum Nauki</Agency><Country/></Grant><Grant><GrantID>Statutory funds</GrantID><Agency>Nencki Institute of Experimental Biology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491778">CACYBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002135">Calcium-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075383">S100 Calcium Binding Protein A6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490164">SUGT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>105504-00-5</RegistryNumber><NameOfSubstance UI="C055351">S100A6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002135" MajorTopicYN="N">Calcium-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075383" MajorTopicYN="N">S100 Calcium Binding Protein A6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CacyBP/SIP</Keyword><Keyword MajorTopicYN="N">Lewy bodies</Keyword><Keyword MajorTopicYN="N">S100A6</Keyword><Keyword MajorTopicYN="N">Sgt1</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neurofibrillary tangles</Keyword><Keyword MajorTopicYN="N">&#x3b2; amyloid plaques</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32492924</ArticleId><ArticleId IdType="pmc">PMC7313082</ArticleId><ArticleId IdType="doi">10.3390/ijms21113979</ArticleId><ArticleId IdType="pii">ijms21113979</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Filipek A., Le&#x15b;niak W. Current view on cellular function of S100A6 and its ligands, CacyBP/SIP and Sgt1. Post. Biochem. 2018;64:242&#x2013;252. doi: 10.18388/pb.2018_136.</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/pb.2018_136</ArticleId><ArticleId IdType="pubmed">30656909</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez L.L., Garrie K., Turner M.D. Role of S100 proteins in health and disease. Biochim. Biophys. Acta. 2020;1867:118677. doi: 10.1016/j.bbamcr.2020.118677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2020.118677</ArticleId><ArticleId IdType="pubmed">32057918</ArticleId></ArticleIdList></Reference><Reference><Citation>Otterbein L.R., Kordowska J., Witte-Hoffmann C., Wang C.L., Dominguez R. Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: The calcium sensor mechanism of S100 proteins revealed at atomic resolution. Structure. 2002;10:557&#x2013;567. doi: 10.1016/S0969-2126(02)00740-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(02)00740-2</ArticleId><ArticleId IdType="pubmed">11937060</ArticleId></ArticleIdList></Reference><Reference><Citation>Moroz O.V., Wilson K.S., Bronstein I.B. The role of zinc in the S100 proteins: Insights from the X-ray structures. Amino Acids. 2011;41:761&#x2013;772. doi: 10.1007/s00726-010-0540-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-010-0540-4</ArticleId><ArticleId IdType="pubmed">20306096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;nicki J., Filipek A., Heimann P., Kaczmarek L., Kami&#x144;ska B. Tissue specific distribution of calcyclin--10.5 kDa Ca2+-binding protein. FEBS Lett. 1989;254:141&#x2013;144. doi: 10.1016/0014-5793(89)81026-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(89)81026-9</ArticleId><ArticleId IdType="pubmed">2776880</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipek A., Puzianowska M., Cieslak B., Kuznicki J. Calcyclin&#x2013;Ca(2+)-binding protein homologous to glial S-100 beta is present in neurones. NeuroReport. 1993;4:383&#x2013;386. doi: 10.1097/00001756-199304000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199304000-00010</ArticleId><ArticleId IdType="pubmed">8499593</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita N., Ilg E.C., Schafer B.W., Heizmann C.W., Kosaka T. Distribution of a specific calcium-binding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system. J. Comp. Neurol. 1999;404:235&#x2013;257. doi: 10.1002/(SICI)1096-9861(19990208)404:2&lt;235::AID-CNE8&gt;3.0.CO;2-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19990208)404:2&lt;235::AID-CNE8&gt;3.0.CO;2-7</ArticleId><ArticleId IdType="pubmed">9934997</ArticleId></ArticleIdList></Reference><Reference><Citation>Le&#x15b;niak W., Wilanowski T., Filipek A. S100A6 - focus on recent developments. Biol. Chem. 2017;398:1087&#x2013;1094. doi: 10.1515/hsz-2017-0125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2017-0125</ArticleId><ArticleId IdType="pubmed">28343163</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurewicz E., Kasacka I., Bankowski E., Filipek A. S100A6 and its extracellular ligands in Wharton&#x2019;s jelly of healthy and preeclamptic patients. Placenta. 2014;35:386&#x2013;391. doi: 10.1016/j.placenta.2014.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2014.03.017</ArticleId><ArticleId IdType="pubmed">24746261</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclerc E., Fritz G., Weibel M., Heizmann C.W., Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 2007;282:31317&#x2013;31331. doi: 10.1074/jbc.M703951200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M703951200</ArticleId><ArticleId IdType="pubmed">17726019</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurewicz E., G&#xf3;ral A., Filipek A. S100A6 is secreted from Wharton&#x2019;s jelly mesenchymal stem cells and interacts with integrin &#x3b2;1. Int. J. Biochem. Cell Biol. 2014;55:298&#x2013;303. doi: 10.1016/j.biocel.2014.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2014.09.015</ArticleId><ArticleId IdType="pubmed">25256682</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurewicz E., Wyroba E., Filipek A. Tubulin-dependent secretion of S100A6 and cellular signaling pathways activated by S100A6-integrin &#x3b2;1 interaction. Cell. Signal. 2018;42:21&#x2013;29. doi: 10.1016/j.cellsig.2017.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2017.10.004</ArticleId><ArticleId IdType="pubmed">29020611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakane K., Nishiguchi M., Denda M., Yamagchi F., Magari M., Kanayama N., Morishita R., Tokumitsu H. Identification and characterization of a centrosomal protein, FOR20 as a novel S100A6 target. Biochem. Biophys. Res. Commun. 2017;491:980&#x2013;985. doi: 10.1016/j.bbrc.2017.07.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.07.161</ArticleId><ArticleId IdType="pubmed">28765046</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dieck J., Lum J.K., Teufel D.P., Fersht A.R. S100 proteins interact with the N-terminal domain of MDM2. FEBS Lett. 2010;584:3269&#x2013;3274. doi: 10.1016/j.febslet.2010.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2010.06.024</ArticleId><ArticleId IdType="pubmed">20591429</ArticleId></ArticleIdList></Reference><Reference><Citation>Graczyk A., S&#x142;omnicki L.P., Le&#x15b;niak W. S100A6 competes with the TAZ2 domain of p300 for binding to p53 and attenuates p53 acetylation. J. Mol. Biol. 2013;425:3488&#x2013;3494. doi: 10.1016/j.jmb.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.06.007</ArticleId><ArticleId IdType="pubmed">23796514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilanczyk E., Graczyk A., Ostrowska H., Kasacka I., Le&#x15b;niak W., Filipek A. S100A6 is transcriptionally regulated by &#x3b2;-catenin and interacts with a novel ligand, lamin A/C, in colorectal cancer cells. Cell Calcium. 2012;51:470&#x2013;477. doi: 10.1016/j.ceca.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2012.04.005</ArticleId><ArticleId IdType="pubmed">22560296</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata M., Shimamoto S., Yamaguchi F., Tokuda M., Tokumitsu H., Kobayashi R. Regulation of nuclear localization signal-importin &#x3b1; interaction by Ca2+/S100A6. FEBS Lett. 2010;584:4517&#x2013;4523. doi: 10.1016/j.febslet.2010.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2010.09.052</ArticleId><ArticleId IdType="pubmed">20965181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartkowska K., Swiatek I., Aniszewska A., Jurewicz E., Turlejski K., Filipek A., Djavadian R.L. Stress-Dependent Changes in the CacyBP/SIP Interacting Protein S100A6 in the Mouse Brain. PLoS ONE. 2017;12:e0169760. doi: 10.1371/journal.pone.0169760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169760</ArticleId><ArticleId IdType="pmc">PMC5221789</ArticleId><ArticleId IdType="pubmed">28068373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagmeyer S., Rom&#xe3;o M.A., Crist&#xf3;v&#xe3;o J.S., Vilella A., Zoli M., Gomes C.M., Grabrucker A.M. Distribution and Relative Abundance of S100 Proteins in the Brain of the APP23 Alzheimer&#x2019;s Disease Model Mice. Front. Neurosci. 2019;13:640. doi: 10.3389/fnins.2019.00640.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00640</ArticleId><ArticleId IdType="pmc">PMC6596341</ArticleId><ArticleId IdType="pubmed">31281238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada J., Jinno S. Upregulation of calcium binding protein, S100A6, in activated astrocytes is linked to glutamate toxicity. Neuroscience. 2012;226:119&#x2013;129. doi: 10.1016/j.neuroscience.2012.08.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.08.068</ArticleId><ArticleId IdType="pubmed">22982625</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiu S.C., Chan W.Y., Heizmann C.W., Sch&#xe4;fer B.W., Shu S.Y., Yew D.T. Differential expression of S100B and S100A6(1) in the human fetal and aged cerebral cortex. Brain Res. Dev. Brain Res. 2000;119:159&#x2013;168. doi: 10.1016/S0165-3806(99)00151-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-3806(99)00151-0</ArticleId><ArticleId IdType="pubmed">10675765</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada J., Jinno S. Age-related differences in oligodendrogenesis across the dorsal-ventral axis of the mouse hippocampus. Hippocampus. 2014;24:1017&#x2013;1029. doi: 10.1002/hipo.22287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22287</ArticleId><ArticleId IdType="pubmed">24753086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjell J., Fischer-Sternjak J., Thompson A.J., Friess C., Sticco M.J., Salinas F., Cox J., Martinelli D.C., Ninkovic J., Franze K., et al. Defining the Adult Neural Stem Cell Niche Proteome Identifies Key Regulators of Adult Neurogenesis. Cell Stem Cell. 2020;26:277&#x2013;293. doi: 10.1016/j.stem.2020.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.01.002</ArticleId><ArticleId IdType="pmc">PMC7005820</ArticleId><ArticleId IdType="pubmed">32032526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalamakis G., Br&#xfc;ne D., Ravichandran S., Bolz J., Fan W., Ziebell F., Stiehl T., Catal&#xe1;-Martinez F., Kupke J., Zhao S., et al. Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain. Cell. 2019;176:1407&#x2013;1419. doi: 10.1016/j.cell.2019.01.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.01.040</ArticleId><ArticleId IdType="pubmed">30827680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P., Sharma A., Fayaz F., Wakode S., Pottoo F.H. Biological signatures of Alzheimer Disease. Curr. Top. Med. Chem. 2020;9:770&#x2013;781. doi: 10.2174/1568026620666200228095553.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026620666200228095553</ArticleId><ArticleId IdType="pubmed">32108008</ArticleId></ArticleIdList></Reference><Reference><Citation>Mietelska-Porowska A., Wasik U., Goras M., Filipek A., Niewiadomska G. Tau protein modifications and interactions: Their role in function and dysfunction. Int. J. Mol. Sci. 2014;15:4671&#x2013;4713. doi: 10.3390/ijms15034671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms15034671</ArticleId><ArticleId IdType="pmc">PMC3975420</ArticleId><ArticleId IdType="pubmed">24646911</ArticleId></ArticleIdList></Reference><Reference><Citation>Popugaeva E., Pchitskaya E., Bezprozvanny I. Dysregulation of neuronal calcium homeostasis in Alzheimer&#x2019;s disease&#x2014;A therapeutic opportunity? Biochem. Biophys. Res. Commun. 2017;483:998&#x2013;1004. doi: 10.1016/j.bbrc.2016.09.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.053</ArticleId><ArticleId IdType="pmc">PMC5303663</ArticleId><ArticleId IdType="pubmed">27641664</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojarski L., Herms J., Kuznicki J. Calcium dysregulation in Alzheimer&#x2019;s disease. Neurochem. Int. 2008;52:621&#x2013;633. doi: 10.1016/j.neuint.2007.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2007.10.002</ArticleId><ArticleId IdType="pubmed">18035450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzaroba L., Alfieri D.F., Colado Sim&#xe3;o A.N., Vissoci Reiche E.M. The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology. 2019;74:230&#x2013;241. doi: 10.1016/j.neuro.2019.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2019.07.007</ArticleId><ArticleId IdType="pubmed">31377220</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Reyes R.E., Nava-Mesa M.O., Vargas-Sanchez K., Ariza-Salamanca D., Mora-Munoz L. Involvement of astrocytes in alzheimer&#x2019;s disease from a neuroinflammatory and oxidative stress perspective. Front. Mol. Neurosci. 2017;10:427. doi: 10.3389/fnmol.2017.00427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00427</ArticleId><ArticleId IdType="pmc">PMC5742194</ArticleId><ArticleId IdType="pubmed">29311817</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost G.R., Li Y.M. The role of astrocytes in amyloid production and Alzheimer&#x2019;s disease. Open Biol. 2017;12:170228. doi: 10.1098/rsob.170228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.170228</ArticleId><ArticleId IdType="pmc">PMC5746550</ArticleId><ArticleId IdType="pubmed">29237809</ArticleId></ArticleIdList></Reference><Reference><Citation>Webers A., Heneka M.T., Gleeson P.A. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer&#x2019;s disease. Immunol. Cell Biol. 2020;98:28&#x2013;41. doi: 10.1111/imcb.12301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12301</ArticleId><ArticleId IdType="pubmed">31654430</ArticleId></ArticleIdList></Reference><Reference><Citation>Boom A., Pochet R., Authelet M., Pradier L., Borghgraef P., Van Leuven F., Heizmann C.W., Brion J.P. Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer&#x2019;s disease and in PS1/APP transgenic mice models. Biochim. Biophys. Acta. 2004;1742:161&#x2013;168. doi: 10.1016/j.bbamcr.2004.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2004.09.011</ArticleId><ArticleId IdType="pubmed">15590066</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Z.Y., Wang C.Y., Wang T., Li Y.C., Wang Z.Y. Glial S100A6 Degrades &#x3b2;-amyloid Aggregation through Targeting Competition with Zinc Ions. Aging Dis. 2019;10:756&#x2013;769. doi: 10.14336/AD.2018.0912.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2018.0912</ArticleId><ArticleId IdType="pmc">PMC6675528</ArticleId><ArticleId IdType="pubmed">31440382</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda A., Tamano H. Insight into cognitive decline from Zn(2+) dynamics through extracellular signaling of glutamate and glucocorticoids. Arch. Biochem. Biophys. 2016;611:93&#x2013;99. doi: 10.1016/j.abb.2016.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2016.06.021</ArticleId><ArticleId IdType="pubmed">27392455</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagmeyer S., Crist&#xf3;v&#xe3;o J.S., Mulvihill J.J.E., Boeckers T.M., Gomes C.M., Grabrucker A.M. Zinc Binding to S100B Affords Regulation of Trace Metal Homeostasis and Excitotoxicity in the Brain. Front. Mol. Neurosci. 2018;10:456. doi: 10.3389/fnmol.2017.00456.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00456</ArticleId><ArticleId IdType="pmc">PMC5776125</ArticleId><ArticleId IdType="pubmed">29386995</ArticleId></ArticleIdList></Reference><Reference><Citation>Haldar B., Hamilton C.L., Solodushko V., Abney K.A., Alexeyev M., Honakanen R.E., Scammell J.G., Coffi D.L. S100A6 is a positive regulator of PPP5C-FKBP51-dependent regulation of endothelial calcium signaling. FASEB J. 2020;34:3179&#x2013;3196. doi: 10.1096/fj.201901777R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201901777R</ArticleId><ArticleId IdType="pmc">PMC7401177</ArticleId><ArticleId IdType="pubmed">31916625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wruck W., Schr&#xf6;ter F., Adjaye J. Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer&#x2019;s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks. J. Alzheimers Dis. 2016;50:1065&#x2013;1082. doi: 10.3233/JAD-150733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150733</ArticleId><ArticleId IdType="pubmed">26890743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyaux D., Alao J., Fuchs J., Kiss R., Keller B., Heizmann C.W., Pochet R., Frermann D. S100A6, a calcium- and zinc-binding protein, is overexpressed in SOD1 mutant mice, a model for amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2000;1498:264&#x2013;272. doi: 10.1016/S0167-4889(00)00101-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4889(00)00101-4</ArticleId><ArticleId IdType="pubmed">11108968</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyaux D., Boom A., Van Den Bosch L., Belot N., Martin J.-J., Heizmann C.W., Kiss R., Pochet R. S100A6 Overexpression within Astrocytes Associated with Impaired Axons from Both ALS Mouse Model and Human Patients. J. Neuropath. Exp. Neurol. 2002;61:736&#x2013;744. doi: 10.1093/jnen/61.8.736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.8.736</ArticleId><ArticleId IdType="pubmed">12152788</ArticleId></ArticleIdList></Reference><Reference><Citation>Iridoy M.O., Zubiri I., Zelaya M.V., Martinez L., Aus&#xed;n K., Lachen-Montes M., Santamar&#xed;a E., Fernandez-Irigoyen J., Jeric&#xf3; I. Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Int. J. Mol. Sci. 2019;20:4. doi: 10.3390/ijms20010004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010004</ArticleId><ArticleId IdType="pmc">PMC6337647</ArticleId><ArticleId IdType="pubmed">30577465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin A.M.G., Shadfar S., Vidal M., Jamali M.S., Atkin J.D. Motor Neuron Susceptibility in ALS/FTD. Front. Neurosci. 2019;13:532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D., Cordera S., Cavalla P., Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 1996;139:27&#x2013;33. doi: 10.1016/0022-510X(96)00073-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00073-1</ArticleId><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>Botelho H.M., Leal S.S., Cardoso I., Yanamandra K., Morozova-Roche L.A., Fritz G., Gomes C.M. S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation. J. Biol. Chem. 2012;287:42233&#x2013;42242. doi: 10.1074/jbc.M112.396416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.396416</ArticleId><ArticleId IdType="pmc">PMC3516767</ArticleId><ArticleId IdType="pubmed">23076148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T., Mane S., Eid T., Zhao H., Lin A., Guan Z., Kim J.H., Schweitzer J., King-Stevens D., Weber P., et al. Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol. Med. 2007;13:1&#x2013;13. doi: 10.2119/2006-00079.Lee.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2006-00079.Lee</ArticleId><ArticleId IdType="pmc">PMC1869627</ArticleId><ArticleId IdType="pubmed">17515952</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacheaux L.P., Ivens S., David Y., Lakhter A.J., Bar-Klein G., Shapira M., Heinemann U., Friedman A., Kaufer D. Transcriptome Profiling Reveals TGF- Signaling Involvement in Epileptogenesis. J. Neurosci. 2009;29:8927&#x2013;8935. doi: 10.1523/JNEUROSCI.0430-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0430-09.2009</ArticleId><ArticleId IdType="pmc">PMC2875073</ArticleId><ArticleId IdType="pubmed">19605630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobori N., Clifton G.L., Dash P. Altered expression of novel genes in the cerebral cortex following experimental brain injury. Mol. Brain Res. 2002;104:148&#x2013;158. doi: 10.1016/S0169-328X(02)00331-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(02)00331-5</ArticleId><ArticleId IdType="pubmed">12225869</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurewicz E., Bednarczyk J., Bot A., Lukasiuk K., Filipek A. Status epilepticus induces long lasting increase in S100A6 expression in astrocytes. Neurochem. Res. 2013;38:1941&#x2013;1948. doi: 10.1007/s11064-013-1100-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-013-1100-6</ArticleId><ArticleId IdType="pubmed">23817846</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Wang H., Zhou X., Mao L., Ding K., Hu Z. Role of mitochondrial calcium uniporter-mediated Ca(2+) and iron accumulation in traumatic brain injury. J. Cell Mol. Med. 2019;23:2995&#x2013;3009. doi: 10.1111/jcmm.14206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14206</ArticleId><ArticleId IdType="pmc">PMC6433723</ArticleId><ArticleId IdType="pubmed">30756474</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang B., Liang M., Yang G., Ye Y., Xu H., He X., Huang J.H. Expression of S100A6 in rat hippocampus after traumatic brain injury due to lateral head acceleration. Int. J. Mol. Sci. 2014;15:6378&#x2013;6390. doi: 10.3390/ijms15046378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms15046378</ArticleId><ArticleId IdType="pmc">PMC4013634</ArticleId><ArticleId IdType="pubmed">24739809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H., Yu J., Chang W., Liu F., He Z. Searching for differentially expressed proteins in spinal cordinjury based on proteomic analysis. Life Sci. 2019;242:117235. doi: 10.1016/j.lfs.2019.117235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.117235</ArticleId><ArticleId IdType="pubmed">31887301</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyaux D., Decaestecker C., Heizmann C.W., Vogl T., Sch&#xe4;fer B.W., Salmon I., Kiss R., Pochet R. S100 proteins in Corpora amylacea from normal human brain. Brain Res. 2000;867:280&#x2013;288. doi: 10.1016/S0006-8993(00)02393-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(00)02393-3</ArticleId><ArticleId IdType="pubmed">10837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipek A., Wojda U. p30, a novel protein target of mouse calcyclin (S100A6) Biochem. J. 1996;320:585&#x2013;587. doi: 10.1042/bj3200585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3200585</ArticleId><ArticleId IdType="pmc">PMC1217969</ArticleId><ArticleId IdType="pubmed">8973570</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipek A., Ku&#x17a;nicki J. Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J. Neurochem. 1998;70:1793&#x2013;1798. doi: 10.1046/j.1471-4159.1998.70051793.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.70051793.x</ArticleId><ArticleId IdType="pubmed">9572262</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzawa S.I., Reed J.C. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell. 2001;7:915&#x2013;926. doi: 10.1016/S1097-2765(01)00242-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)00242-8</ArticleId><ArticleId IdType="pubmed">11389839</ArticleId></ArticleIdList></Reference><Reference><Citation>Jastrzebska B., Filipek A., Nowicka D., Kaczmarek L., Kuznicki J. Calcyclin (S100A6) binding protein (CacyBP) is highly expressed in brain neurons. J. Histochem. Cytochem. 2000;48:1195&#x2013;1202. doi: 10.1177/002215540004800903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/002215540004800903</ArticleId><ArticleId IdType="pubmed">10950876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurewicz E., Miazga K., Fabczak H., S&#x142;awi&#x144;ska U., Filipek A. CacyBP/SIP in the rat spinal cord in norm and after transection&#x2014;Influence on the phosphorylation state of ERK1/2 and p38 kinases. Neurochem. Int. 2020 doi: 10.1016/j.neuint.2020.104757. accepted.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2020.104757</ArticleId><ArticleId IdType="pubmed">32544715</ArticleId></ArticleIdList></Reference><Reference><Citation>Topolska-Wo&#x15b; A.M., Chazin W.J., Filipek A. CacyBP/SIP--Structure and variety of functions. Biochim. Biophys. Acta. 2016;1860:79&#x2013;85. doi: 10.1016/j.bbagen.2015.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2015.10.012</ArticleId><ArticleId IdType="pubmed">26493724</ArticleId></ArticleIdList></Reference><Reference><Citation>Topolska-Wo&#x15b; A.M., Shell S.M., Kila&#x144;czyk E., Szczepanowski R.H., Chazin W.J., Filipek A. Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: The influence of oxidative stress. FASEB J. 2015;29:1711&#x2013;1724. doi: 10.1096/fj.14-264770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.14-264770</ArticleId><ArticleId IdType="pmc">PMC4415008</ArticleId><ArticleId IdType="pubmed">25609429</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;ral A., Bieganowski P., Prus W., Krzemie&#x144;-Ojak &#x141;., K&#x105;dzio&#x142;ka B., Fabczak H., Filipek A. Calcyclin Binding Protein/Siah-1 Interacting Protein Is A Hsp90 Binding Chaperone. PLoS ONE. 2016;11:e0156507. doi: 10.1371/journal.pone.0156507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156507</ArticleId><ArticleId IdType="pmc">PMC4889068</ArticleId><ArticleId IdType="pubmed">27249023</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipek A., Schneider G., Mietelska A., Figiel I., Niewiadomska G. Age-dependent changes in neuronal distribution of CacyBP/SIP: Comparison to tubulin and the tau protein. J. Neural. Transm. 2008;115:1257&#x2013;1264. doi: 10.1007/s00702-008-0062-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-008-0062-3</ArticleId><ArticleId IdType="pubmed">18506390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasik U., Schneider G., Mietelska-Porowska A., Mazurkiewicz M., Fabczak H., Weis S., Zabke C., Harrington C.R., Filipek A., Niewiadomska G. Calcyclin binding protein and Siah-1 interacting protein in Alzheimer&#x2019;s disease pathology: Neuronal localization and possible function. Neurobiol. Aging. 2013;5:1380&#x2013;1388. doi: 10.1016/j.neurobiolaging.2012.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.11.007</ArticleId><ArticleId IdType="pubmed">23260124</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher J., Peraza L.R., Firbank M., Thomas A.J., Kaiser M., Gallagher P., O&#x2019;Brien J.T., Blamire A.M., Taylor J.P. Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain. 2019;142:1767&#x2013;1782. doi: 10.1093/brain/awz069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz069</ArticleId><ArticleId IdType="pmc">PMC6536851</ArticleId><ArticleId IdType="pubmed">30938426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Gonz&#xe1;lez-Morales A., Iloro I., Elortza F., Ferrer I., Gveric D., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Unveiling the olfactory proteostatic disarrangement in Parkinson&#x2019;s disease by proteome-wide profiling. Neurobiol. Aging. 2019;73:123&#x2013;134. doi: 10.1016/j.neurobiolaging.2018.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.018</ArticleId><ArticleId IdType="pubmed">30342273</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte J., Littleton J.T. The biological function of the Huntingtin protein and its relevance to Huntington&#x2019;s Disease pathology. Curr. Trends. Neurol. 2011;5:65&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3237673</ArticleId><ArticleId IdType="pubmed">22180703</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeredys M., Gruszczynska-Biegala J., Schach T., Methner A., Kuznicki J. Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington&#x2019;s disease. Front. Mol. Neurosci. 2013;6:42. doi: 10.3389/fnmol.2013.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2013.00042</ArticleId><ArticleId IdType="pmc">PMC3838962</ArticleId><ArticleId IdType="pubmed">24324398</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;ral A., Bartkowska K., Djavadian R.L., Filipek A. CacyBP/SIP, a Hsp90 binding chaperone, in cellular stress response. Int. J. Biochem. Cell Biol. 2018;99:178&#x2013;185. doi: 10.1016/j.biocel.2018.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2018.04.012</ArticleId><ArticleId IdType="pubmed">29660399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara K., Kanai S., Sago H., Yamakawa K., Akiba S. Comparative proteomic profiling reveals aberrant cell proliferation in the brain of embryonic Ts1Cje, a mouse model of Down syndrome. Neuroscience. 2014;281:1&#x2013;15. doi: 10.1016/j.neuroscience.2014.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.09.039</ArticleId><ArticleId IdType="pubmed">25261685</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonarakis S.E., Skotko B.G., Rafii M.S., Strydom A., Pap S.E., Bianchi D.W., Sherman S.L., Reeves R.H. Down syndrome. Nat. Rev. Dis. Primers. 2020;6:9. doi: 10.1038/s41572-019-0143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0143-7</ArticleId><ArticleId IdType="pubmed">32029743</ArticleId></ArticleIdList></Reference><Reference><Citation>Matigian N., Windus L., Smith H., Filippich C., Pantelis C., McGrath J., Mowry B., Hayward N.H. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol. Psychiatry. 2007;2:815&#x2013;825. doi: 10.1038/sj.mp.4001998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4001998</ArticleId><ArticleId IdType="pubmed">17440432</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre R.S., Calabrese J.R. Bipolar depression: The clinical characteristics and unmet needs of a complex disorder. Curr. Med. Res. Opin. 2019;35:1993&#x2013;2005. doi: 10.1080/03007995.2019.1636017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2019.1636017</ArticleId><ArticleId IdType="pubmed">31311335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitagawa K., Skowyra D., Elledge S.J., Harper J.W., Hieter P. SGT1 encodes an essential component of the yeast kinetochore assembly pathway and a novel subunit of the SCF ubiquitin ligase complex. Mol. Cell. 1999;4:21&#x2013;33. doi: 10.1016/S1097-2765(00)80184-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)80184-7</ArticleId><ArticleId IdType="pubmed">10445024</ArticleId></ArticleIdList></Reference><Reference><Citation>Niikura Y., Kitagawa K. Functions of SGT1, a Co-chaperone. In: Asea A.A., Kaur P., editors. Heat Shock Protein 90 in Human Diseases and Disorders. Springer; Basel, Switzerland: 2019. pp. 317&#x2013;370.</Citation></Reference><Reference><Citation>Spiechowicz M., Bernstein H.G., Dobrowolny H., Le&#x15b;niak W., Mawrin C., Bogerts B., Ku&#x17a;nicki J., Filipek A. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer&#x2019;s disease brain. Neurochem. Int. 2006;49:487&#x2013;493. doi: 10.1016/j.neuint.2006.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2006.03.009</ArticleId><ArticleId IdType="pubmed">16698122</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohush A., Niewiadomska G., Weis S., Filipek A. HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson&#x2019;s Disease and Dementia with Lewy Bodies. J. Parkinson&#x2019;s Dis. 2019;9:97&#x2013;107. doi: 10.3233/JPD-181443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-181443</ArticleId><ArticleId IdType="pmc">PMC6398563</ArticleId><ArticleId IdType="pubmed">30741686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>